Back
Enliven Therapeutics Vs. IGC Pharma Industry Stock Comparison
Buy
58
ELVN
Enliven Therapeutics
Last Price:
27.82
Seasonality Move:
-12%
Sell
39
IGC
IGC Pharma
Last Price:
0.39
Seasonality Move:
-8.21%
Buy
58
Enliven Therapeutics (ELVN)
is a Buy
Is Enliven Therapeutics a Buy, Sell or Hold?
- The current Enliven Therapeutics [ELVN] share price is $28.38. The Score for ELVN is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- ELVN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
IGC Pharma (IGC)
is a Sell
Is IGC Pharma a Buy, Sell or Hold?
- The current IGC Pharma [IGC] share price is $0.40. The Score for IGC is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- IGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ELVN Stock Price Chart
What is Enliven Therapeutics's stock price today?
-
The Enliven Therapeutics share price today is $28.38
The current trend is moderately bullish and ELVN is experiencing slight selling pressure.
IGC Stock Price Chart
What is IGC Pharma's stock price today?
-
The IGC Pharma share price today is $0.40
The current trend is moderately bullish and IGC is experiencing buying pressure, which is a positive indicator for future bullish movement.
ELVN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.04 | Buy |
Relative Strength Index (14 RSI): | 62.6 | Buy |
Chaikin Money Flow: | -29113 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.01 - 28.99) | Buy |
Bollinger Bands (100): | (21.59 - 26.47) | Buy |
IGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.01 | Buy |
Relative Strength Index (14 RSI): | 55.26 | Buy |
Chaikin Money Flow: | 40623 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.36 - 0.4) | Buy |
Bollinger Bands (100): | (0.36 - 0.44) | Sell |
ELVN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.77 | Sell |
20-day SMA: | 28.12 | Buy |
50-day SMA: | 25.08 | Buy |
200-day SMA: | 21.13 | Buy |
8-day EMA: | 28.56 | Sell |
20-day EMA: | 27.79 | Buy |
50-day EMA: | 25.97 | Buy |
200-day EMA: | 21.93 | Buy |
IGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.4 | Sell |
20-day SMA: | 0.38 | Buy |
50-day SMA: | 0.37 | Buy |
200-day SMA: | 0.41 | Sell |
8-day EMA: | 0.4 | Buy |
20-day EMA: | 0.39 | Buy |
50-day EMA: | 0.39 | Buy |
200-day EMA: | 0.4 | Buy |
Enliven Therapeutics Earnings Growth & ELVN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.18 per share, and a decrease next year of $0.48 per share.
IGC Pharma Earnings Growth & IGC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.09 per share.
Enliven Therapeutics Technical Analysis
Oct 17 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
17 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
IGC Pharma Technical Analysis
Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |